Kanghong Pharmaceutical (002773.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 784 million, down 24.09% year on year.

Zhitong Finance APP News, Kanghong Pharmaceutical (002773.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 3.172 billion yuan, a year-on-year decrease of 12.48%; net profit attributable to shareholders of the listed company was 784 million yuan, a year-on-year decrease of 24.09%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 792 million yuan, a year-on-year decrease of 22.65%; basic earnings per share were 0.85 yuan.